Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation.
Hôpital Notre-Dame, Montreal, Quebec, Canada.
S
S
Busque
A
A
Shoker
D
D
Landsberg
V
V
McAlister
P
P
Halloran
J
J
Shapiro
J
J
Peets
M
M
Schulz
D000208:Acute Disease; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D002170:Canada; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000276:immunology*; D008055:Lipids / Q000097:blood; D008775:Methylprednisolone / Q000008:administration & dosage; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D011241:Prednisone / Q000008:administration & dosage; D016559:Tacrolimus / Q000008:administration & dosage
D015415:Biomarkers; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D008055:Lipids; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus; D008775:Methylprednisolone